Lucitanib

CAS : 1058137-23-7

Ref. 3D-ISB13723

Informations sur le produit

• Nom: Lucitanib
• CAS: 1058137-23-7

Description

Lucitanib is a potent anti-tumor agent that inhibits the growth of cancer cells by inhibiting the production of vascular endothelial growth factor receptor 1 (VEGFR1). It also has antiangiogenic properties. Lucitanib has been shown to inhibit the proliferation of cancer cells in vitro and in vivo. A mouse tumor model was used to study the effects of lucitanib, which showed a significant inhibition of tumor size. In addition, lucitanib inhibited IL-2 receptor expression, leading to an increase in apoptosis of T lymphocytes and natural killer cells. The drug also showed potent antitumor activity against carcinoma cell lines in vitro. The LC-MS/MS method was used for identification and quantification of lucitanib in biological samples from breast cancer patients.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 443.49 g/mol
• Formule: C₂₆H₂₅N₃O₄
• Degré de pureté: Min. 95%